If you have tracked every macro, joined the gym, cut carbs, and still cannot move the scale, the problem extends beyond lifestyle factors. It’s physiological weight loss resistance. At Meeting Point Health in Philadelphia, led by Dr. Stephen Matta, DO, and Mary Anne Matta, MS, MA, LAc, weight is treated as a signal of metabolic dysfunction rather than a math problem. Our targeted combination of comprehensive testing and peptide therapy gets to the root of what is actually driving resistance.

What this article covers:

  • Why diet and exercise alone often fail
  • The lab work we run before prescribing
  • How GLP-1s actually work
  • Customized dosing of GLP-1s 
  • GLP-1 benefits beyond weight loss

Why Am I Not Losing Weight Even Though I’m Doing Everything Right?

Weight loss resistance happens when multiple systems are signaling the body to store fat and hold onto it. These mechanisms rarely appear alone, and most patients have two or three at work. Some common contributing factors are the following: 

  • Insulin resistance: Elevated fasting insulin blocks fat breakdown and pushes circulating glucose into storage. This can run for years before fasting glucose or HbA1c leave the standard reference range. 
  • Chronic low-grade inflammation: Inflammatory cytokines disrupt leptin signaling in the hypothalamus, which is why some patients never quite feel full.
  • Thyroid and cortisol dysregulation: Impaired T4 to T3 conversion plus chronically elevated cortisol suppresses metabolic rate.
  • Gut dysfunction and toxic load: Microbiome imbalance and accumulated environmental toxins produce metabolic endotoxemia, impairing mitochondrial efficiency and fat oxidation.
  • Poor sleep: Fragmented sleep raises evening cortisol and ghrelin and lowers next-day insulin sensitivity, independent of diet.

What Lab Work Should I Get Before Starting a GLP-1?

Starting peptide therapy without a biological map is guesswork. Diagnostic testing ensures appropriate treatment targets, and your provider may want a closer look at these markers: 

  • Metabolic & Glycemic: Key insulin and blood sugar markers to evaluate overall glucose handling and insulin sensitivity.
  • Inflammation: Standard markers that indicate systemic stress or hidden drivers stalling progress.
  • Thyroid & Endocrine: Thyroid function and stress hormone panels to assess overall metabolic rate.
  • Cardiovascular & Liver Health: Standard lipid profiles and liver enzymes to monitor baseline processing capacity.
  • Micronutrients: Essential vitamin, mineral, and iron levels.

Because GLP-1 peptides naturally reduce overall food volume, identifying existing micronutrient levels before caloric intake drops helps prevent avoidable fatigue, hair thinning, and muscle loss down the line.

How Do GLP-1s Actually Work?

GLP-1 is a gut hormone that regulates blood sugar, appetite, and metabolism. Receptor agonist peptides mimic it, enhancing glucose-dependent insulin secretion, slowing gastric emptying, and steadying blood sugar. They also reduce food noise, the intrusive preoccupation with eating that makes dietary change feel impossible for some.

They are not a shortcut. What they do is lower the physiological resistance that defeated your previous attempts, opening a window where lifestyle change actually holds. What is done inside that window matters for the outcome. 

Since nutritional intake is likely to decrease on GLP-1 therapy, we offer some recommendations to prevent muscle loss and optimize health during the process:

  • Protein and anti-inflammatory nutrition: At least 1 gram per kilogram body weight, more in older adults, with adequate fiber and hydration to manage the constipation that follows slowed gastric emptying.
  • Resistance training two to three times weekly: This activity will help to preserve and build muscle throughout treatment. 
  • Electrolyte and micronutrient monitoring. Focusing on balanced, colorful meals ensures a broad variety of essential micronutrients within smaller food volumes. Pairing daily hydration with targeted electrolytes keeps energy levels stable and prevents common early adjustment symptoms like fatigue.

Can Dosing Be Customized for GLP-1 Therapy?

Yes. Effective GLP-1 therapy is never one-size-fits-all, and more is not always better. Optimal protocol depends on individual tolerance, overall goals, and the specific type of GLP-1 medication used. Rather than forcing a standard escalation schedule, adjusting dose and frequency prioritizes comfort and steady physiological progress. Specific options are tailored directly during clinical consultation and follow-ups with the providers. To get started with your customized protocol, click here to schedule a discovery call with a team member at Meeting Point Health.

Do GLP-1s Have Other Benefits? 

GLP-1 medicines do far more than assist in weight loss. Emerging clinical research confirms that these peptides act on deep cellular and anti-inflammatory pathways to protect major organ systems, with many of these therapeutic benefits occurring independent of total weight loss.

  • Cardiovascular & Heart Protection: Major clinical trials demonstrate a significant reduction in risk for heart attack, stroke, and cardiovascular mortality. GLP-1s also improve functional capacity and symptoms in individuals dealing with heart failure with preserved ejection fraction..
  • Liver Restoration: Targeted GLP-1 activation directly reduces visceral organ fat, helps resolve liver inflammation, and aids in preventing or reversing liver fibrosis.
  • Kidney Health & Preservation: By easing systemic inflammatory burden and stabilizing vascular control, these protocols slow the progression of chronic kidney disease (CKD) and lower the risk of renal failure.
  • Joint Pain & Systemic Inflammation: Beyond structural unloading from weight reduction, direct central anti-inflammatory signaling may help to ease systemic joint pain.
  • Airway & Respiratory Improvement: Reduced metabolic congestion and inflammatory load contribute to significant decreases in the frequency and severity of obstructive sleep apnea (OSA) events.

Getting Started With GLP-1 Therapy in Philadelphia

Care at Meeting Point Health begins with comprehensive testing and a full history, including everything you have already tried. We identify which blocks are actually present, treat them alongside peptide therapy rather than after it, recheck labs at intervals, and track body composition rather than the scale alone. The goal is not the fastest possible loss. It is a metabolic system that functions well enough to hold the result. 

Click here to schedule a discovery call and see if GLP-1 therapy is right for you. 

Helpful Links: 

Related Reading:

Frequently Asked Questions

Who is a good candidate for GLP-1 therapy? Adults with a BMI over 27 plus metabolic concerns, people with insulin resistance or prediabetes, patients with type 2 diabetes seeking better glycemic control, and those pursuing supervised cardiometabolic optimization. Candidacy comes from evaluation and labs, not BMI alone.

What side effects are common with GLP-1 therapy? Most are mild and fade over the first weeks. Nausea during dose adjustment is most common; constipation, temporary fatigue, and minor injection-site reactions occur less often. Slow titration, hydration, and electrolyte attention keep them manageable. Report any persistent vomiting, severe abdominal pain, or signs of dehydration promptly.

Will I lose muscle on a GLP-1? Not if it’s managed correctly. In order to help prevent lean mass loss from day one, it is important to integrate strength training and high-protein targets into your routine, while tracking body composition instead of weight alone.

How fast will I see results from a GLP-1? Appetite change, reduced food noise, and steadier blood sugar often appear within weeks. Body composition and broader metabolic improvement build over months. 

What happens when I stop taking a GLP-1? Some regaining of weight after discontinuation is common, which is exactly why the root-cause work matters. Patients who have corrected insulin resistance, inflammation, and hormonal dysfunction, and who work to preserve muscle, are in a far better position than those who relied on the medication alone.

References

Gonzalez-Rellan, M. J., & Drucker, D. J. (2025). The expanding benefits of GLP-1 medicines. Cell reports. Medicine, 6(7), 102214. https://doi.org/10.1016/j.xcrm.2025.102214

Written by Amanda Bates, RN and medically reviewed by Dr. Stephen Matta.